684 related articles for article (PubMed ID: 11018095)
1. Serum C-peptide, insulin-like growth factor (IGF)-I, IGF-binding proteins, and colorectal cancer risk in women.
Kaaks R; Toniolo P; Akhmedkhanov A; Lukanova A; Biessy C; Dechaud H; Rinaldi S; Zeleniuch-Jacquotte A; Shore RE; Riboli E
J Natl Cancer Inst; 2000 Oct; 92(19):1592-600. PubMed ID: 11018095
[TBL] [Abstract][Full Text] [Related]
2. Plasma insulin-like growth factor-I, insulin-like growth factor-binding proteins, and prostate cancer risk: a prospective study.
Stattin P; Bylund A; Rinaldi S; Biessy C; Déchaud H; Stenman UH; Egevad L; Riboli E; Hallmans G; Kaaks R
J Natl Cancer Inst; 2000 Dec; 92(23):1910-7. PubMed ID: 11106682
[TBL] [Abstract][Full Text] [Related]
3. A prospective study of plasma C-peptide and colorectal cancer risk in men.
Ma J; Giovannucci E; Pollak M; Leavitt A; Tao Y; Gaziano JM; Stampfer MJ
J Natl Cancer Inst; 2004 Apr; 96(7):546-53. PubMed ID: 15069117
[TBL] [Abstract][Full Text] [Related]
4. Plasma C-peptide, insulin-like growth factor-I, insulin-like growth factor binding proteins and risk of colorectal cancer in a nested case-control study: the Japan public health center-based prospective study.
Otani T; Iwasaki M; Sasazuki S; Inoue M; Tsugane S;
Int J Cancer; 2007 May; 120(9):2007-12. PubMed ID: 17266031
[TBL] [Abstract][Full Text] [Related]
5. Prediagnostic levels of C-peptide, IGF-I, IGFBP -1, -2 and -3 and risk of endometrial cancer.
Lukanova A; Zeleniuch-Jacquotte A; Lundin E; Micheli A; Arslan AA; Rinaldi S; Muti P; Lenner P; Koenig KL; Biessy C; Krogh V; Riboli E; Shore RE; Stattin P; Berrino F; Hallmans G; Toniolo P; Kaaks R
Int J Cancer; 2004 Jan; 108(2):262-8. PubMed ID: 14639613
[TBL] [Abstract][Full Text] [Related]
6. Milk intake, circulating levels of insulin-like growth factor-I, and risk of colorectal cancer in men.
Ma J; Giovannucci E; Pollak M; Chan JM; Gaziano JM; Willett W; Stampfer MJ
J Natl Cancer Inst; 2001 Sep; 93(17):1330-6. PubMed ID: 11535708
[TBL] [Abstract][Full Text] [Related]
7. Prospective study of colorectal cancer risk in men and plasma levels of insulin-like growth factor (IGF)-I and IGF-binding protein-3.
Ma J; Pollak MN; Giovannucci E; Chan JM; Tao Y; Hennekens CH; Stampfer MJ
J Natl Cancer Inst; 1999 Apr; 91(7):620-5. PubMed ID: 10203281
[TBL] [Abstract][Full Text] [Related]
8. A prospective study of C-peptide, insulin-like growth factor-I, insulin-like growth factor binding protein-1, and the risk of colorectal cancer in women.
Wei EK; Ma J; Pollak MN; Rifai N; Fuchs CS; Hankinson SE; Giovannucci E
Cancer Epidemiol Biomarkers Prev; 2005 Apr; 14(4):850-5. PubMed ID: 15824155
[TBL] [Abstract][Full Text] [Related]
9. Gender difference in the association of insulin and the insulin-like growth factor axis with colorectal neoplasia.
Yamaji T; Iwasaki M; Sasazuki S; Tsugane S
Int J Obes (Lond); 2012 Mar; 36(3):440-7. PubMed ID: 21673650
[TBL] [Abstract][Full Text] [Related]
10. Serum C-peptide, IGFBP-1 and IGFBP-2 and risk of colon and rectal cancers in the European Prospective Investigation into Cancer and Nutrition.
Jenab M; Riboli E; Cleveland RJ; Norat T; Rinaldi S; Nieters A; Biessy C; Tjønneland A; Olsen A; Overvad K; Grønbaek H; Clavel-Chapelon F; Boutron-Ruault MC; Linseisen J; Boeing H; Pischon T; Trichopoulos D; Oikonomou E; Trichopoulou A; Panico S; Vineis P; Berrino F; Tumino R; Masala G; Peters PH; van Gils CH; Bueno-de-Mesquita HB; Ocké MC; Lund E; Mendez MA; Tormo MJ; Barricarte A; Martínez-García C; Dorronsoro M; Quirós JR; Hallmans G; Palmqvist R; Berglund G; Manjer J; Key T; Allen NE; Bingham S; Khaw KT; Cust A; Kaaks R
Int J Cancer; 2007 Jul; 121(2):368-76. PubMed ID: 17372899
[TBL] [Abstract][Full Text] [Related]
11. Circulating levels of insulin-like growth factors, their binding proteins, and breast cancer risk.
Schernhammer ES; Holly JM; Pollak MN; Hankinson SE
Cancer Epidemiol Biomarkers Prev; 2005 Mar; 14(3):699-704. PubMed ID: 15767352
[TBL] [Abstract][Full Text] [Related]
12. Circulating levels of insulin-like growth factor I, its binding proteins -1,-2, -3, C-peptide and risk of postmenopausal breast cancer.
Keinan-Boker L; Bueno De Mesquita HB; Kaaks R; Van Gils CH; Van Noord PA; Rinaldi S; Riboli E; Seidell JC; Grobbee DE; Peeters PH
Int J Cancer; 2003 Aug; 106(1):90-5. PubMed ID: 12794762
[TBL] [Abstract][Full Text] [Related]
13. Insulin-like growth factor I (IGF-I), IGF-binding proteins, and breast cancer.
Krajcik RA; Borofsky ND; Massardo S; Orentreich N
Cancer Epidemiol Biomarkers Prev; 2002 Dec; 11(12):1566-73. PubMed ID: 12496045
[TBL] [Abstract][Full Text] [Related]
14. The differential regulation of the circulating levels of the insulin-like growth factors and their binding proteins (IGFBP) 1, 2 and 3 after elective abdominal surgery.
Cotterill AM; Mendel P; Holly JM; Timmins AG; Camacho-Hübner C; Hughes SC; Ross RM; Blum WF; Langford RM
Clin Endocrinol (Oxf); 1996 Jan; 44(1):91-101. PubMed ID: 8706300
[TBL] [Abstract][Full Text] [Related]
15. A prospective study of insulin-like growth factor-I, IGF-binding proteins-1, -2 and -3 and lung cancer risk in women.
Lukanova A; Toniolo P; Akhmedkhanov A; Biessy C; Haley NJ; Shore RE; Riboli E; Rinaldi S; Kaaks R
Int J Cancer; 2001 Jun; 92(6):888-92. PubMed ID: 11351312
[TBL] [Abstract][Full Text] [Related]
16. Insulin-like growth factors, their binding proteins, and prostate cancer risk: analysis of individual patient data from 12 prospective studies.
Roddam AW; Allen NE; Appleby P; Key TJ; Ferrucci L; Carter HB; Metter EJ; Chen C; Weiss NS; Fitzpatrick A; Hsing AW; Lacey JV; Helzlsouer K; Rinaldi S; Riboli E; Kaaks R; Janssen JA; Wildhagen MF; Schröder FH; Platz EA; Pollak M; Giovannucci E; Schaefer C; Quesenberry CP; Vogelman JH; Severi G; English DR; Giles GG; Stattin P; Hallmans G; Johansson M; Chan JM; Gann P; Oliver SE; Holly JM; Donovan J; Meyer F; Bairati I; Galan P
Ann Intern Med; 2008 Oct; 149(7):461-71, W83-8. PubMed ID: 18838726
[TBL] [Abstract][Full Text] [Related]
17. Gene expression and serum levels of insulin-like growth factors (IGFs) and IGF-binding proteins in a case of non-islet cell tumour hypoglycaemia.
Holt RI; Teale JD; Jones JS; Quin JD; McGregor AM; Miell JP
Growth Horm IGF Res; 1998 Dec; 8(6):447-54. PubMed ID: 10985756
[TBL] [Abstract][Full Text] [Related]
18. [Association of insulin, insulin-like growth factor and insulin-like growth factor binding proteins with the risk of colorectal cancer].
Jiang B; Liu DB; Zhang X; DU LL; Han CZ
Zhonghua Wei Chang Wai Ke Za Zhi; 2009 May; 12(3):264-8. PubMed ID: 19434535
[TBL] [Abstract][Full Text] [Related]
19. Insulin, the insulin-like growth factor axis, and mortality in patients with nonmetastatic colorectal cancer.
Wolpin BM; Meyerhardt JA; Chan AT; Ng K; Chan JA; Wu K; Pollak MN; Giovannucci EL; Fuchs CS
J Clin Oncol; 2009 Jan; 27(2):176-85. PubMed ID: 19064975
[TBL] [Abstract][Full Text] [Related]
20. Insulin-like growth factor (IGF)-I, IGF-II, IGF binding protein-3, and risk of colorectal cancer: a nested case-control study in the Japan Collaborative Cohort study.
Suzuki S; Kojima M; Tokudome S; Suzuki K; Ozasa K; Ito Y; Inaba Y; Tajima K; Nakachi K; Watanabe Y; Tamakoshi A;
Asian Pac J Cancer Prev; 2009 Dec; 10 Suppl():45-9. PubMed ID: 20553081
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
